ArticleNucleic acids research2025
Adaptive evolution of oriC through in vitro propagation of a mini-chromosome in RCR.
Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A self-replicating artificial module-genome that generates bacterial chromosome replication system in vitro.Nucleic acids research · 2026Article
- Mechanisms of chromosomal DNA replication in Escherichia coli and Bacillus subtilis.FEMS microbiology reviews · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Diversification and selective propagation are the main driving forces of evolution, resulting in the emergence of organisms possessing various strategies. Here, we conducted in vitro evolution of the replication origin (oriC) under the pressure of an AT-rich mini-chromosome amplification using a reconstituted Escherichia coli replication-cycle reaction (RCR). Using next-generation sequencing, we identified that these evolved oriCs contain select mutations within the duplex unwinding element (DUE) and DnaA-binding site (DnaA box) regions, which are crucial for replication initiation. Real-time detection of RCR amplification (real-time RCR) revealed that the DUE mutations, which decreased the GC content, along with the introduction of a specific A/T sequence in DUE-M and a consecutive KAK (K = T or G) motif in DUE-R, enhanced the RCR amplification efficiency compared to the wild-type oriC (oriCwt). A competitive amplification assay also elucidated that the DnaA box mutations confer a competitive advantage over coexistent oriCwt. Although these DUE and DnaA box mutations were selected through the same amplification reaction, they exhibited distinct competitive amplification strategies. The DUE mutant represents a faster propagation strategy (r-strategy), while the DnaA box mutant represents an adaptive strategy with a competitive advantage (K-strategy), representing the r/K-selection theory in molecular evolution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.